MYC Induced Nuclear Antigen (MINA) Peptide
MINA
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN980090
Aperçu rapide pour MYC Induced Nuclear Antigen (MINA) Peptide (ABIN980090)
Antigène
MINA
(MYC Induced Nuclear Antigen (MINA))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-MINA antibody (Catalog #: ARP39722_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- MINA (MYC Induced Nuclear Antigen (MINA))
-
Sujet
-
MINA protein is directly involved in ribosome biogenesis, most likely during the assembly process of preribosomal particles. MINA is also involved in cell proliferation. MINA may have a role in esophageal squamous cell carcinoma, colon cancer and lung cancer
Alias Symbols: MDIG, NO52, MINA53
Protein Interaction Partner: MINA,MYC,MINA
Protein Size: 464 -
Poids moléculaire
- 53 kDa
-
ID gène
- 84864
-
NCBI Accession
- NM_032778, NP_116167
-
UniProt
- Q96KB0
Antigène
-
Vous êtes ici:
